Pharma Two B Ltd.: Clinical Trials

1 trial sponsored by Pharma Two B Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Pharma Two B Ltd.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease
P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),, Placebo, P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), - Parkinson's Disease
Phase 2 / Phase 3CompletedPharma Two B Ltd.1492013-12-012023-04-07

Conditions studied

Parkinson Disease (1)

Interventions

Pramipexole (1)  ·  rasagiline (1)

Countries

Israel (1)  ·  United States (1)